About us

GFBiochemicals is the only company to produce levulinic acid derivatives at commercial scale directly from biomass. The company was co-founded in 2008 by Pasquale Granata and Mathieu Flamini.

Our founders worked closely with a group of biobased chemical experts to find sustainable alternatives to oil-based products across a range of market sectors. Together, they developed the production technology needed for this revolution in chemicals, in partnership with the University of Pisa and the Polytechnic University of Milan, the technology’s potential was demonstrated by the Caserta plant which has been retrofitted with new conversion, recovery and purification technology.

GFBiochemicals expects substantial growth in the levulinic acid market in the coming years.

In February 2016, GFBiochemicals acquired Segetis, the leading producer of levulinic acid derivatives, in a move towards downstream integration. This acquisition marked a transformational step for GFBiochemicals enabling the combined business to create high-value derivatives from levulinic acid produced using GFBiochemicals’ patented technology. Segetis provides GFBiochemicals with a market-leading brand and unique intellectual property composed of over 50 patents and over 200 pending patent applications worldwide, as well as a production plant located in Minnesota.

GFBiochemicals head quarter is in Geleen, the Netherlands.

Our team of technical experts have decades of experience in innovation, production and business development. Funded and supported by private investors, GFBiochemicals is committed for the long-term.

In 2020 GFBiochemicals announced a Joint Venture with Towell Engineering Group of Oman for the production and marketing of biochemicals using GFBiochemicals proprietary technology. The aim of the Joint Venture Company, NXTLEVVEL Biochem (

Our Mission

GFBiochemicals is bringing biobased levulinic acid derivatives to market through technology innovation. Levulinic acid is a platform chemical with significant potential to replace petroleum-based products in the chemical and biofuel sectors. GFBiochemicals has proprietary technology and a commercial-scale plant in Caserta, Italy.

Our Vision

Our proprietary technology portfolio and experience makes GFBiochemicals a leader in the field. Customers tap into the potential of a unique chemical portfolio, based on levulinic acid. This approach will further enable new applications for versatile chemical platform products, which we support with in-house process development, production and commercialization.

Clear need for new sustainable chemical building blocks

Societal challenge today

  • "Blacklisted" solvents
  • Phtalate plasticizers in marine life
  • Use of bisphenol A
  • Diluted and fossil-based detergents
  • Fuels causing air pollution
  • Biofuels from vegetable oils

Solution with levulinic acid

  • Green solvents
  • Biodegradable plasticizers for flexible PVC
  • Epoxy resins based on diphenolic acid
  • Highly concentrated biobased detergents
  • Clean-burning fuels and fuel components
  • Fuels derived from cellulosic biomass waste

Focused on levulinic acid production since 2008

Mission: Bringing levulinic acid to the market by technology innovation
Lease Caserta plant to develop and demo breakthrough technologies
Rebranding Green Future to GFBiochemicals
Key personnel from global leaders enforce GFBiochemicals to further develop the technologies
Plant Start-up
Novel technology implemented in July 2015
GFB Americas
Acquisition of Segetis assets, IP and trademarks
Joint Venture announcement
Facility of Levulinic acid derivatives of 30Kta

GFB production plant

Levulinic acid produced by GFBiochemicals' technology is sourced from abundant renewable feedstocks. Given GFBiochemicals' flexibility in inputs, biomass from a variety of sources can be converted.

GFBiochemicals technology is the first to enable cost effective production of levulinate derivatives at industrial scale.

GFBiochemicals' staff and technical experts have decades of experience in innovation, production and business development. Funded and supported by private investors, GFBiochemicals is committed for the long-term.